
Sign up to save your podcasts
Or


On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.

293 Listeners

50 Listeners

28,492 Listeners

112,194 Listeners

149 Listeners

867 Listeners

50 Listeners

5,467 Listeners

6,089 Listeners

124 Listeners

2,073 Listeners

83 Listeners